News | March 02, 2012

Molecular Breast Imaging: Better Way to Spot Tumors in Dense Breast Tissue

March 2, 2012 — Mayo Clinic researchers have developed a new tool to better identify tumors in women with dense breast tissue. The technology, called molecular breast imaging (MBI) is covered in the February issue of Mayo Clinic Health Letter.

Breasts are a mixture of fatty and dense tissue. About one-half of women younger than age 50 have breast tissue considered dense on mammogram images; the same is true for about one-third of women over 50. On a mammogram, dense tissue and tumors both appear white. Spotting a tumor in dense tissue has been compared to looking through a frosted glass window.

MBI offers a clearer picture and detects three times as many cancers in women with dense breast tissue than traditional mammography does. Like mammography, MBI requires that the breast be compressed between two plates. However, MBI needs only about one-third of the pressure used for a mammogram. Prior to the imaging, a short-lived radioactive tracer is injected into the woman’s arm vein. Two 10-minute images are taken of each breast using gamma radiation. (Radiation levels from MBI are comparable to the dose that’s delivered from one digital screening mammogram.) If tumor cells are present, they absorb the tracer like a sponge and illuminate on the image.

MBI supplements – rather than replaces – mammography, which remains an accurate screening tool in women with non-dense breasts. The U.S. Food and Drug Administration (FDA) approved MBI as a screening tool in 2010. While not widely available at all medical centers, that is expected to change over the next few years.

 

Related Content

Breast Cancer Screening Performance Impacted by Mean Mammographic Compression Pressure
News | Mammography | December 08, 2017
Dutch researchers demonstrated a strong relationship between compression pressure in mammography and breast cancer...
Sponsored Content | Videos | Mammography | December 06, 2017
Martin Yaffe, Ph.D., FAAPM, senior scientist, physical sciences/imaging research, Sunnybrook Health Sciences Centre,
Ikonopedia and Konica Minolta Showcase Integrated Breast Imaging Workflow and Reporting at RSNA
News | Breast Imaging | December 05, 2017
Ikonopedia and Konica Minolta Healthcare Americas Inc. showcased integrated breast imaging workflow and reporting at...
Sponsored Content | Videos | Breast Imaging | December 05, 2017
Stamatia Destounis, M.D., FACR, associate professor, University of Rochester School of Medicine, attending radiologis
Numerous Studies Highlight Importance of Quantitative Breast Imaging Analysis at RSNA 2017
News | Breast Density | November 30, 2017
The importance of quantitative analysis in breast imaging was the focus of numerous abstracts accepted for presentation...
Hologic Receives FDA 510(k) Clearance of Quantra 2.2 Breast Density Assessment Software
Technology | Breast Density | November 28, 2017
Hologic Inc. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its...
Eizo RadiForce RX560 Monitor Receives FDA 510(k) for Tomosynthesis and Digital Mammography
Technology | November 20, 2017
Eizo Corp. announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for breast tomosynthesis...
Kansas City Radiology Center Employs iCAD PowerLook Tomo Detection for DBT
News | Computer-Aided Detection Software | November 10, 2017
November 10, 2017 — Imaging for Women, a leading radiology center in Kansas City, Mo., announced it is now using iCAD
Kubtec Brings Image Analytics Capabilities to Tomosynthesis Specimen Imaging Systems
News | Mammography | November 10, 2017
Kubtec announced it will be showcasing new image analytics capabilities on its advanced tomosynthesis specimen imaging...
Fujifilm Highlights Women's Health and Pediatrics at RSNA 2017
News | Information Technology | November 08, 2017
November 8, 2017 — Fujifilm Healthcare will showcase a variety of imaging and information technology solutions at the
Overlay Init